Sex differences on new-onset heart failure in patients with known or suspected coronary artery disease

European Journal of Preventive Cardiology

10 May 2021
Organised by: Logo
ESC Journals

Abstract

AbstractAims

The impact of sex in patients with CAD has been widely reported, but little is known about the influence of sex on the risk of new-onset HF in patients with known or suspected CAD. We aimed to examine sex-related differences and new-onset heart failure (HF) risk in patients with known or suspected coronary artery disease (CAD) undergoing vasodilator stress cardiac magnetic resonance (CMR).

Methods and results

We prospectively evaluated 5899 consecutive HF-free patients submitted to stress CMR for known or suspected CAD. Ischaemic burden (number of segments with stress-induced perfusion deficit) and left ventricular ejection fraction (LVEF) were assessed by CMR. The association between sex and new-onset HF (including outpatient diagnosis or acute HF hospitalization) was evaluated using a Cox proportional hazards regression model adjusted for competing events [death, myocardial infarction (MI), and revascularization]. A total of 2289 (38.8%) patients were women. During a median follow-up of 4.5 years, 610 (10.3%) patients died, 191 (3.2%) suffered an MI, 905 (15.3%) underwent revascularization, and 314 (5.3%) developed new-onset HF. Unadjusted new-onset HF rates were higher in women than in men (1.25 vs. 0.83 per 100 person-years, P = 0.001). After comprehensive multivariate adjustment, women showed an increased risk of new-onset HF (hazard ratio 1.58, 95% confidence interval 1.18–2.10; P = 0.002). We found a sex-differential effect along the continuum of LVEF (P-value for interaction = 0.007). At lower LVEF, there was an increased risk in both sexes. However, compared with men, the risk of new-onset HF was higher in women with LVEF >55%.

Conclusion

Women with known or suspected CAD are at a higher risk of new-onset HF. Further studies are needed to unravel the mechanisms behind these sex-related differences.

Contributors

Julio Núñez
Julio Núñez

Author

Instituto de Investigacion Sanitaria INCLIVA Valencia , Spain

Patricia Palau
Patricia Palau

Author

Valencia University Clinical Hospital Valencia , Spain

Cesar Ríos-Navarro
Cesar Ríos-Navarro

Author

Research Foundation Hospital of Valencia (INCLIVA) Valencia , Spain

Antoni Bayés-Genís
Antoni Bayés-Genís

Author

University Hospital Germans Trias and Pujol de Badalona Badalona , Spain

Vicent Bodí
Vicent Bodí

Author

University of Valencia Valencia , Spain

ESC 365 is supported by